U.S. sues Adobe over subscription plan disclosures

U.S. sues Adobe over subscription plan disclosures


Adobe headquarters in San Jose, California, US, on Thursday, Nov. 30, 2023.

David Paul Morris | Bloomberg | Getty Images

The U.S. government on Monday sued Adobe, accusing the maker of Photoshop and Acrobat of harming consumers by enrolling them in its most lucrative subscription plans without clearly disclosing important terms.

In a complaint filed in the San Jose, California, federal court, the government said Adobe failed to adequately disclose hefty early termination fees, sometimes reaching hundreds of dollars, when customers sign up for “annual, paid monthly” subscription plans.

The government said Adobe hides important terms in fine print and behind textboxes and hyperlinks, clearly discloses the fees only when subscribers try to cancel, and makes canceling an onerous and complicated process.

Monday’s lawsuit seeks civil fines, an injunction and other remedies.

Adobe did not immediately respond to a request for comment.



Source

South Korea keeps rates steady as FX risks limit easing scope
World

South Korea keeps rates steady as FX risks limit easing scope

South Korea’s central bank kept interest rates unchanged as widely expected on Thursday as a tumbling won reduced the scope for further easing and policymakers waited to see how the government’s steps to cool Seoul’s property market play out. The Bank of Korea’s monetary policy board voted to keep the benchmark interest rate unchanged at 2.50%, in line […]

Read More
Hong Kong tower fire toll rises to 44, police arrest three
World

Hong Kong tower fire toll rises to 44, police arrest three

Thick smoke and flames rise as a major fire engulfs several apartment blocks at the Wang Fuk Court residential estate in Hong Kong’s Tai Po district on Nov. 26, 2025. Yan Zhao | Afp | Getty Images  A huge fire still burning in a Hong Kong residential apartment complex that has killed at least 44 […]

Read More
Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies
World

Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies

Drug pricing has emerged as a key topic to watch for pharmaceutical companies and investors in 2025. As President Donald Trump pushes for lower medicine prices for Americans, the sector is facing additional pricing pressure from a Biden-era law called the Inflation Reduction Act. The IRA, voted into law in 2022, allows the Centers for […]

Read More